Zymeworks, Inc.
(NYSE : ZYME)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.46%145.100.7%$935.89m
PFEPfizer Inc. -0.61%35.780.9%$910.70m
MRKMerck & Co., Inc. 0.71%83.220.7%$707.22m
ABBVAbbVie, Inc. -0.83%86.421.9%$646.70m
BMYBristol-Myers Squibb Co. -0.66%58.601.0%$606.17m
LLYEli Lilly & Co. -0.47%149.101.1%$553.63m
AZNAstraZeneca Plc -2.26%54.401.2%$244.75m
NVSNovartis AG -1.27%86.340.2%$163.18m
GSKGlaxoSmithKline Plc -1.06%37.390.2%$102.06m
PRNBPrincipia Biopharma, Inc. 0.02%99.970.0%$95.68m
NVONovo Nordisk A/S -1.20%68.570.1%$56.34m
SNYSanofi 0.49%50.860.2%$48.90m
RGENRepligen Corp. -2.13%139.357.1%$47.20m
OPKOPKO Health, Inc. 2.79%3.1411.2%$46.27m
RPRXRoyalty Pharma Plc -6.18%39.200.2%$41.64m

Company Profile

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.